Success and failures in MRSA infection control during the COVID-19 pandemic
Abstract Private sector facilities in the United States have experienced a resurgence of Methicillin-resistant Staphylococcus aureus (MRSA) hospital-onset infections during the COVID-19 pandemic, which eliminated all gains that were achieved over the last decade. The third quarter of 2021, the Stand...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-09-01
|
| Series: | Antimicrobial Resistance and Infection Control |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13756-022-01158-z |
| _version_ | 1818017625172606976 |
|---|---|
| author | Kevin T. Kavanagh Lindsay E. Cormier |
| author_facet | Kevin T. Kavanagh Lindsay E. Cormier |
| author_sort | Kevin T. Kavanagh |
| collection | DOAJ |
| description | Abstract Private sector facilities in the United States have experienced a resurgence of Methicillin-resistant Staphylococcus aureus (MRSA) hospital-onset infections during the COVID-19 pandemic, which eliminated all gains that were achieved over the last decade. The third quarter of 2021, the Standardized Infection Ratio for hospital onset MRSA bloodstream infections was 1.17, well above the baseline value of 1.0. In contrast, the Veterans Health Administration (VHA) has been able to maintain its mitigation efforts and low rates of MRSA hospital-onset infections through the second quarter of fiscal year 2022 (Mar. 31, 2022), the most recent available data. The difference may be explained not only by the VHA’s use of uniform mitigating policies which rely on active surveillance and contact precautions, but also on the VAH’s ability to maintain adequate staffing during the pandemic. Future research into MRSA mitigation is warranted and this data supports the need for healthcare system transformation. |
| first_indexed | 2024-04-14T07:29:21Z |
| format | Article |
| id | doaj.art-a4e2e788e2d24040a4d67099756e8ba9 |
| institution | Directory Open Access Journal |
| issn | 2047-2994 |
| language | English |
| last_indexed | 2024-04-14T07:29:21Z |
| publishDate | 2022-09-01 |
| publisher | BMC |
| record_format | Article |
| series | Antimicrobial Resistance and Infection Control |
| spelling | doaj.art-a4e2e788e2d24040a4d67099756e8ba92022-12-22T02:05:54ZengBMCAntimicrobial Resistance and Infection Control2047-29942022-09-011111410.1186/s13756-022-01158-zSuccess and failures in MRSA infection control during the COVID-19 pandemicKevin T. Kavanagh0Lindsay E. Cormier1Health Watch USAHealth Watch USA, Eastern Kentucky UniversityAbstract Private sector facilities in the United States have experienced a resurgence of Methicillin-resistant Staphylococcus aureus (MRSA) hospital-onset infections during the COVID-19 pandemic, which eliminated all gains that were achieved over the last decade. The third quarter of 2021, the Standardized Infection Ratio for hospital onset MRSA bloodstream infections was 1.17, well above the baseline value of 1.0. In contrast, the Veterans Health Administration (VHA) has been able to maintain its mitigation efforts and low rates of MRSA hospital-onset infections through the second quarter of fiscal year 2022 (Mar. 31, 2022), the most recent available data. The difference may be explained not only by the VHA’s use of uniform mitigating policies which rely on active surveillance and contact precautions, but also on the VAH’s ability to maintain adequate staffing during the pandemic. Future research into MRSA mitigation is warranted and this data supports the need for healthcare system transformation.https://doi.org/10.1186/s13756-022-01158-zMRSAVeterans Health AdministrationVHAPandemicSARS-CoV-2healthcare associated infections |
| spellingShingle | Kevin T. Kavanagh Lindsay E. Cormier Success and failures in MRSA infection control during the COVID-19 pandemic Antimicrobial Resistance and Infection Control MRSA Veterans Health Administration VHA Pandemic SARS-CoV-2 healthcare associated infections |
| title | Success and failures in MRSA infection control during the COVID-19 pandemic |
| title_full | Success and failures in MRSA infection control during the COVID-19 pandemic |
| title_fullStr | Success and failures in MRSA infection control during the COVID-19 pandemic |
| title_full_unstemmed | Success and failures in MRSA infection control during the COVID-19 pandemic |
| title_short | Success and failures in MRSA infection control during the COVID-19 pandemic |
| title_sort | success and failures in mrsa infection control during the covid 19 pandemic |
| topic | MRSA Veterans Health Administration VHA Pandemic SARS-CoV-2 healthcare associated infections |
| url | https://doi.org/10.1186/s13756-022-01158-z |
| work_keys_str_mv | AT kevintkavanagh successandfailuresinmrsainfectioncontrolduringthecovid19pandemic AT lindsayecormier successandfailuresinmrsainfectioncontrolduringthecovid19pandemic |